We are live on ! Find out more
BJCM

Blue Jay Capital Management Portfolio holdings

AUM $147M
1-Year Est. Return 64.18%
This Fund
S&P 500
This Quarter Est. Return
+19.22%
1 Year Est. Return
+64.18%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$285M
AUM Growth
+$60.8M
Cap. Flow
+$35.3M
Cap. Flow %
12.39%
Top 10 Hldgs %
55.03%
Holding
34
New
11
Increased
9
Reduced
1
Closed
13

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$16.1M
2
ENDP
Endo International plc
ENDP
+$14.6M
3
AKRX
Akorn Inc
AKRX
+$13.6M
4
UTHR icon
United Therapeutics
UTHR
+$11.4M
5
IPXL
Impax Laboratories, Inc.
IPXL
+$11.3M

Top Sells

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$12.5M
2
SNN icon
Smith & Nephew
SNN
+$12.5M
3
MDCO
Medicines Co
MDCO
+$11.1M
4
BIIB icon
Biogen
BIIB
+$11M
5
MOH icon
Molina Healthcare
MOH
+$9.63M

Sector Composition

Rank Sector Weight
1 Healthcare 83.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRGO icon
26
Perrigo
PRGO
$1.39B
– –
-75,000
Closed -$12.5M
SNN icon
27
Smith & Nephew
SNN
$13.2B
– –
-339,500
Closed -$12.5M
ZTS icon
28
Zoetis
ZTS
$32.4B
– –
-205,000
Closed -$8.82M
WMGI
29
DELISTED
Wright Medical Group Inc
WMGI
– –
-342,500
Closed -$9.2M
MDCO
30
DELISTED
Medicines Co
MDCO
– –
-400,000
Closed -$11.1M
HNT
31
DELISTED
HEALTH NET INC
HNT
– –
-170,000
Closed -$9.1M
SIRO
32
DELISTED
SIRONA DENTAL SYSTEMS INC COM STK
SIRO
– –
-102,500
Closed -$8.96M
CTRX
33
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
– –
-160,000
Closed -$8.28M
GEVA
34
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
– –
-80,000
Closed -$7.42M
1
2

Similar funds

BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
RJA
Robshaw & Julian Associates Williamsville, New York $140M AUM 13.69% 1-Year Est. Return
RP
Ridgegate Proprietary Sydney, Australia $154M AUM 25.47% 1-Year Est. Return
ACPVT
ABS Capital Partners V Trust Baltimore, Maryland $123M AUM
SFA
Staton Financial Advisors Charlotte, North Carolina $118M AUM 11.07% 1-Year Est. Return
KL
Kinsight LLC Birmingham, Alabama $176M AUM 17.21% 1-Year Est. Return
KFS
Kissinger Financial Services Hunt Valley, Maryland $100M AUM 6.22% 1-Year Est. Return
FHC
First Houston Capital Houston, Texas $100M AUM 23.45% 1-Year Est. Return

Blue Jay Capital Management's Q1 2015 Portfolio in Review

As of Q1 2015, Blue Jay Capital Management held 34 positions worth $285M, up 27% from $224M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Blue Jay Capital Management deployed $35.3M of net new capital in Q1 2015, opening 11 new positions and adding to 9 existing holdings. Its largest new stake was Alkermes: 235,000 shares worth $14.3M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 79% a quarter earlier.

On the sell side, the largest reduction was Cooper Companies, an estimated $2.53M trimmed.

  • Blue Jay Capital Management's largest Q1 2015 buy was Alkermes: 235,000 shares worth $14.3M.
  • Blue Jay Capital Management added most to Intuitive Surgical in Q1 2015, an estimated $7.39M increase.
  • Blue Jay Capital Management's biggest Q1 2015 reduction was Cooper Companies, cutting an estimated $2.53M.
  • Blue Jay Capital Management fully exited Perrigo in Q1 2015, selling an estimated $12.5M.
  • Blue Jay Capital Management's ten largest holdings make up 55% of its $285M portfolio in Q1 2015.
  • Blue Jay Capital Management opened 11 new positions and closed 13 in Q1 2015.
  • Blue Jay Capital Management's portfolio value rose 27% quarter-over-quarter to $285M.

Based on Blue Jay Capital Management's 13F filing for Q1 2015, filed 13 May 2015.